Bill Title: Requires coverage for drugs under certain conditions and the drug is approved by the United States Food and Drug Administration. (1/1/23) (EN INCREASE SG EX See Note)

Spectrum: Partisan Bill (Republican 1-0)

Status: (Passed) 2022-06-18 - Effective date 1/1/2023. [SB394 Detail]

---

Bill Drafts

Revision	Date	Format	Source	View
Chaptered	Not Avail	PDF	Link	View
Enrolled	Not Avail	PDF	Link	View
Engrossed	Not Avail	PDF	Link	View
Engrossed	Not Avail	PDF	Link	View
Introduced	Not Avail	PDF	Link	View

Amendments

Amendment	Date	Disposition	Format	Source	View
Senate Committee Amendment #1846 INS Proposed	Not Avail	Proposed	PDF	Link	View
Senate Committee Amendment #1700 INS Draft	Not Avail	Proposed	PDF	Link	View
Senate Floor Amendment #2029 Bernard Adopted	Not Avail	Adopted	PDF	Link	View
House Committee Amendment #3756 INS Draft	Not Avail	Proposed	PDF	Link	View
House Committee Amendment #3783 INS Proposed	Not Avail	Proposed	PDF	Link	View

Supplemental Documents

Title	Description	Date	Format	Source	View
Analysis	Digest of SB394 Original	Not Avail	PDF	Link	View
Analysis	Digest of SB394 Engrossed	Not Avail	PDF	Link	View
Analysis	Digest of SB394 Reengrossed	Not Avail	PDF	Link	View
Fiscal Note	Fiscal Note - SB394 ReEngrossed	Not Avail	PDF	Link	View
Analysis	House Committee Redigest of SB394	Not Avail	PDF	Link	View
Fiscal Note	Fiscal Note - SB394 ReEngrossed With House Cmte Amendments	Not Avail	PDF	Link	View
Analysis	Summary of House Amendments to SB394	Not Avail	PDF	Link	View
Fiscal Note	Fiscal Note - SB394 Enrolled	Not Avail	PDF	Link	View
Analysis	Resume Digest for SB394	Not Avail	PDF	Link	View

Social Comments on LA SB394